Medical journey of patients with polycystic ovary syndrome and obesity: a cross-sectional survey of patients and primary care physicians
Open Access
- 12 November 2022
- journal article
- research article
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 135 (3) , 312-320
Abstract
Patients with polycystic ovary syndrome (PCOS) report dissatisfaction with the diagnostic process and are more likely to have overweight or obesity. We wanted to understand the role that primary care physicians (PCPs) play in the diagnosis of PCOS and how they contribute to treatment of patients with PCOS and obesity. A cross-sectional online survey was completed by 251 patients with PCOS and obesity (BMI ≥30 kg/m2) and 305 healthcare providers (PCPs, obstetricians/gynecologists, reproductive and general endocrinologists). This paper focuses on the 75 PCPs treating patients with PCOS and obesity. In the most common patient journey, we found that most patients with PCOS and obesity (53%) have initial discussions about PCOS symptoms with PCPs. However, less than one quarter of patients receive a PCOS diagnosis (22%) or initial treatment (24%) for PCOS from a PCP. One quarter of patients also reported receiving a misdiagnosis from a PCP prior to their PCOS diagnosis. Compared to other healthcare providers surveyed, PCPs were the least comfortable making a PCOS diagnosis. Compared to PCPs without an obesity management focus, PCPs with an obesity management focus were more likely to diagnose patients themselves (38% vs 62%) and initiate PCOS treatment themselves (42% vs 57%). According to PCPs, difficulty with obesity management (47%) was the top reason that patients with PCOS and obesity stop seeing them for PCOS management. PCPs are often the initial medical touchpoint for patients with PCOS and obesity. However, PCPs play a smaller role in diagnosis and treatment of PCOS. Increasing education on obesity management may encourage PCPs to diagnose and treat more patients with PCOS and offer strategies to help patients with obesity management.Keywords
Funding Information
- Novo Nordisk, Inc. (USA) employees of which had a role in the analysis and interpretation of the data
This publication has 37 references indexed in Scilit:
- Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic LabyrinthInternational Journal of Reproductive Medicine, 2014
- Polycystic Ovary Syndrome: Effect and Mechanisms of Acupuncture for Ovulation InductionEvidence-Based Complementary and Alternative Medicine, 2013
- Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysisHuman Reproduction Update, 2012
- Polycystic Ovary Syndrome in the United States: Clinical Visit Rates, Characteristics, and Associated Health Care CostsArchives of internal medicine (1960), 2011
- How Accurate are Self-Reports? Analysis of Self-Reported Health Care Utilization and Absence When Compared With Administrative DataJournal of Occupational and Environmental Medicine, 2009
- Use of metformin in polycystic ovary syndromeAmerican Journal of Obstetrics and Gynecology, 2008
- Abdominal adiposity and the polycystic ovary syndromeTrends in Endocrinology & Metabolism, 2007
- Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society GuidelineThe Journal of Clinical Endocrinology & Metabolism, 2006
- Health Care-Related Economic Burden of the Polycystic Ovary Syndrome during the Reproductive Life SpanThe Journal of Clinical Endocrinology & Metabolism, 2005
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndromeFertility and Sterility, 2004